Viridian Therapeutics, Inc.\DE

By person

23 insiders · 71 transactions

1.1×

Stephen Mahoney holds only 1.1 times base salary in stock. $811.69K of shares against $700.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Stephen Mahoney last reported holding, valued at $24.50, the price Common Stock was last bought or sold at on the open market here, on 19 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Fairmount Funds Management LLC entity

Director

$90.00M (6)

—

+$90.00M

5,617,321

4.96%

$137.62M

+15,907%

Violin Jonathan

Chief Executive Officer

—

$4.27M (10)

−$4.27M

430,905

0.3803%

$10.56M

—

Katz Barrett

Chief Medical Officer

—

$3.17M (4) scheduled

−$3.17M

0.0000%

$0.00

—

Booth Bruce

Director

$3.00M (1)

—

+$3.00M

3,142,580

2.77%

$76.99M

+21.0%

Meisner Lara

Chief Legal Officer

—

$2.54M (14) scheduled

−$2.54M

29,971

0.0265%

$734.29K

−50.0%

Logos Global Master Fund LP entity

10% owner

$2.27M (3)

—

+$2.27M

550,000

0.4855%

$13.48M

+650.0%

Frazier Life Sciences Public Fund, L.P. entity

10% owner

$2.20M (1)

—

+$2.20M

1,505,200

1.33%

$36.88M

+15.3%

LEFKOFF KYLE

Director

—

$540.14K (10)

−$540.14K

463,473

0.4091%

$11.36M

−7.4%

Mahoney Stephen F.

President and CEO

$499.26K (1)

—

+$499.26K

33,130

0.0292%

$811.69K

+3,213%

Tousignant Jennifer

Chief Legal Officer

—

$418.99K (3) scheduled

−$418.99K

0.0000%

$0.00

−100.0%

Myers Scott Dunseth

Chief Executive Officer

$261.80K (2)

—

+$261.80K

259,500

0.2291%

$6.36M

—

Beetham Thomas W.

Chief Operating Officer

$117.05K (1)

—

+$117.05K

13,271

0.0117%

$325.14K

+563.6%

Levy Adam Scott

Chief Business Officer

$51.51K (2)

—

+$51.51K

13,040

0.0115%

$319.48K

+247.7%

Hughes Thomas E.

Director

$47.70K (1)

$96.00K (1)

−$48.30K

12,827

0.0113%

$314.26K

−8.7%

Riccitelli Samuel D

President & CEO

—

571,370

0.5043%

$14.00M

+20.4%

LEBOW BENNETT S

Director

—

429,441

0.3791%

$10.52M

+187.9%

Marshall William Stuart

See Remarks

—

273,146

0.2411%

$6.69M

+73.6%

FAVORITO TAMARA A

CFO, Secretary, Treasurer

—

106,447

0.0940%

$2.61M

+294.3%

Leverone Jason A.

Chief Financial Officer

—

48,829

0.0431%

$1.20M

+885.1%

Tripuraneni Radhika

Chief Medical Officer

—

40,000

0.0353%

$980.00K

—

Harmon Seth

Chief Financial Officer

—

7,790

0.0069%

$190.86K

+115.6%

Smith Robin L

Director

—

1,900

0.0017%

$46.55K

+171.4%

Gonyer David A

Director

—

1,899

0.0017%

$46.53K

+171.7%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Tripuraneni Radhika

14 Aug 2026

Chief Medical Officer

Exercised, kept

40,000

$13.21

$528.40K

Fairmount Funds Management LLC

10 Jun 2025

Director

Exercised, kept indirect

12,500

$12.31

$153.88K

Fairmount Funds Management LLC

9 Jun 2025

Director

Exercised, kept indirect

1,600

$7.80

$12.48K

Leverone Jason A.

13 Mar 2020

CFO, Treasurer & Secretary

Exercised, kept

11,249

$0.57

$6.41K

Leverone Jason A.

23 Aug 2019

CFO, Treasurer & Secretary

Exercised, kept

3,093

$0.57

$1.76K

Leverone Jason A.

7 Aug 2018

CFO, Treasurer & Secretary

Exercised, kept

29,530

$0.57

$16.83K

Marshall William Stuart

13 Feb 2018

President & CEO

Exercised, kept

115,818

$0.57

$66.02K

LEBOW BENNETT S

13 Feb 2017

Director

Exercised, kept

279,067

$5.39

$1.50M

Gonyer David A

8 Feb 2017

Director

Exercised, kept

1,200

$7.65

$9.18K

Smith Robin L

3 Feb 2017

Director

Exercised, kept

1,200

$7.65

$9.18K

LEBOW BENNETT S

3 Feb 2017

Director

Exercised, kept

1,200

$7.65

$9.18K

Show all 71 transactions →

Viridian Therapeutics, Inc.\DE

By person

Individual transactions

What was left out